BIOMAT Database Logo BIOMAT Database Logo

Regulation of insulin-like growth factor-I and binding protein-3 expression in oMtla-oGH transgenic mice. 1994

J C Chow, and J D Murray, and D Pomp, and R L Baldwin, and C C Calvert, and A M Oberbauer
Department of Animal Science, School of Veterinary Medicine, University of California-Davis 95616.

Growth hormone (GH)-transgenic mice provide a model for studying hormonal regulation of gene products responsible for efficient lean growth. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (BP-3) are two products involved in mediating the growth promoting actions of GH. Mice carrying the ovine metallothionein la-ovine growth hormone (oMtla-oGH) transgene were used to study GH regulation of IGF-I and BP-3 expression because these mice do not exhibit elevated basal oGH levels without transgene stimulation by exogenous zinc. C57B1/6XCBA mice with (transgenic = TG) and without control = C) the oMtla-oGH transgene were activated (+ Zn) or inactivated (-Zn) by the addition or removal of 25 mM zinc sulfate in the drinking water. Plasma IGF-I and BP-3 levels were determined by radioimmunoassay and western ligand blotting, respectively. Hepatic IGF-I and BP-3 mRNA levels were determined by slot-blot analysis. TG+Zn mice had higher plasma IGF-I (p < 0.05) and hepatic IGF-I mRNA (p < 0.05) levels as compared to TG-Zn, C+Zn and C-Zn mice. Plasma IGF-I and hepatic IGF-I mRNA levels in TG-Zn mice were not different from C+Zn and C-Zn mice. Removal of Zn decreased hepatic IGF-I mRNA levels to C levels in TG mice. Plasma BP-3 and hepatic BP-3 mRNA levels in TG+Zn mice were increased (p < 0.05) as compared to TG-Zn, C-Zn and C+Zn. Plasma BP-3 and hepatic BP-3 mRNA levels did not differ between TG-Zn, C-Zn and C+Zn mice. Expression of the transgene also increased the level of plasma BP-3 during pregnancy as compared to that observed for pregnant C mice. We conclude that oGH regulates IGF-I and BP-3 expression in the oMtla-oGH transgenic mouse model system.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008668 Metallothionein A low-molecular-weight (approx. 10 kD) protein occurring in the cytoplasm of kidney cortex and liver. It is rich in cysteinyl residues and contains no aromatic amino acids. Metallothionein shows high affinity for bivalent heavy metals. Isometallothionein,Metallothionein A,Metallothionein B,Metallothionein I,Metallothionein II,Metallothionein IIA
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006131 Growth Inhibitors Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth ( Cell Growth Inhibitor,Cell Growth Inhibitors,Growth Inhibitor,Growth Inhibitor, Cell,Growth Inhibitors, Cell,Inhibitor, Cell Growth,Inhibitor, Growth,Inhibitors, Cell Growth,Inhibitors, Growth

Related Publications

J C Chow, and J D Murray, and D Pomp, and R L Baldwin, and C C Calvert, and A M Oberbauer
Expression of human insulin-like growth factor-binding protein-3 in transgenic mice.
December 1995, Journal of molecular endocrinology,
J C Chow, and J D Murray, and D Pomp, and R L Baldwin, and C C Calvert, and A M Oberbauer
Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I.
August 1992, Endocrinology,
J C Chow, and J D Murray, and D Pomp, and R L Baldwin, and C C Calvert, and A M Oberbauer
Expression of insulin-like growth factor-I in transgenic mice.
August 1993, Annals of the New York Academy of Sciences,
J C Chow, and J D Murray, and D Pomp, and R L Baldwin, and C C Calvert, and A M Oberbauer
Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice.
November 2002, American journal of physiology. Endocrinology and metabolism,
J C Chow, and J D Murray, and D Pomp, and R L Baldwin, and C C Calvert, and A M Oberbauer
Insulin-like growth factor-I and insulin-like growth factor binding protein-3 inhibit involution of the mammary gland following lactation: studies in transgenic mice.
January 1995, Progress in growth factor research,
J C Chow, and J D Murray, and D Pomp, and R L Baldwin, and C C Calvert, and A M Oberbauer
Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice.
May 2001, Endocrinology,
J C Chow, and J D Murray, and D Pomp, and R L Baldwin, and C C Calvert, and A M Oberbauer
Insights from insulin-like growth factor binding protein transgenic mice.
October 2002, Endocrinology,
J C Chow, and J D Murray, and D Pomp, and R L Baldwin, and C C Calvert, and A M Oberbauer
Regulation of insulin-like growth factor binding protein-3 expression by dexamethasone.
December 1990, Molecular and cellular endocrinology,
J C Chow, and J D Murray, and D Pomp, and R L Baldwin, and C C Calvert, and A M Oberbauer
Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.
December 2012, The Journal of clinical endocrinology and metabolism,
J C Chow, and J D Murray, and D Pomp, and R L Baldwin, and C C Calvert, and A M Oberbauer
Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I.
September 1991, Endocrinology,
Copied contents to your clipboard!